Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Electric Sensor Detects DNA for Disease Diagnosis

By LabMedica International staff writers
Posted on 01 Sep 2009
A newly developed electrical DNA biosensor will help to characterize pathogens and measure mRNA levels during expression profiling. More...
It will be suitable for point-of-care (POC) diagnosis and criminal investigations.

Scientists in Singapore developed the new electronic sensor that will offer a faster, less expensive, and more practical alternative to tests now used to detect DNA. The new lab-on-a-chip test will lead to wider, more convenient use of DNA testing.

Zhiqiang Gao, Ph.D., at the Institute of Bioengineering and Nanotechnology (IBN; Singapore) and colleagues developed a nanogap sensor. They used a pair of micro-sized metal electrodes separated by a nanogap, 1/50,000 the width of a human hair, in combination with special chemical probes to capture tiny segments of DNA. The newly formed circuit then translated the presence of DNA into an electrical signal that that was measured by a computer. In laboratory tests, the sensor showed excellent sensitivity at detecting trace amounts of human DNA.

Another feature of the biosensor was its ability to capture DNA strands more effectively. The two surfaces of the sensor were coated with a chemically treated capture probe solution through an electrochemical technique specially developed by IBN. This allowed DNA strands to stick more easily to the sensor, resulting in a faster and more accurate analysis.

Current methods for detecting DNA use the polymerase chain reaction (PCR), which amplifies trace amounts of DNA, making it easier to detect the genetic material. The amplification step is one of the reasons why PCR tests can be expensive, cumbersome, and imprecise. The newly developed biosensor should eliminate the need for DNA amplification altogether.

"This new biosensor holds significant promise to speed up on-going efforts in the detection and diagnosis of debilitating diseases such as cancer, cardiovascular problems, and infectious viruses. We aim to make healthcare accessible to the masses with early disease diagnosis as the critical driving force behind the research we undertake here at IBN," said Jackie Y. Ying, Ph.D., executive director of IBN.

The study was published in the September 2, 2009, issue of the Journal of the American Chemical Society.

Related Links:

Institute of Bioengineering and Nanotechnology



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Urine Analyzer
respons® UDS100
New
Alzheimer's Disease Biomarker Assay
Elecsys Phospho-Tau (217P) Plasma
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker assays expand access to ultrasensitive blood-based testing in China (Photo courtesy of Quanterix Corporation)

Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

Quanterix Corporation (Billerica, MA, USA) and Innovita Biological Technology Co., Ltd. (Beijing, China) announced regulatory approvals that expand access to Quanterix SIMOA technology and neurology biomarker... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.